The European Commission  issued a revised questions and answers guideline on implementing safety features for medicinal products detailed in Commission Delegated Regulation (EU) 2016/161.
 
The revised document includes three new questions and answers as well as one revised answer from the previous version.

 

SAFETY FEATURES FOR MEDICINAL PRODUCTS FOR HUMAN USE